Schell T - Search Results

1

Reduced sensitivity to affiliation and psychopathic traits.

Waller R, Corbett N, Raine A, Wagner NJ, Broussard A, Edmonds D, Reardon S, Jones C, Itkin-Ofer M, Schell T, Neumann CS. Waller R, et al. Among authors: schell t. Personal Disord. 2021 Sep;12(5):437-447. doi: 10.1037/per0000423. Epub 2020 Jun 25. Personal Disord. 2021. PMID: 32584095

2

Estimating the real-world usage of mobile apps for mental health: development and application of two novel metrics.

Wasil AR, Gillespie S, Schell T, Lorenzo-Luaces L, DeRubeis RJ. Wasil AR, et al. Among authors: schell t. World Psychiatry. 2021 Feb;20(1):137-138. doi: 10.1002/wps.20827. World Psychiatry. 2021. PMID: 33432761 Free PMC article. No abstract available.

3

Early liver transplant for alcohol-associated liver disease has excellent survival but higher rates of harmful alcohol use.

Musto JA, Palmer G, Nemer M, Schell T, Waclawik G, Glover Q, Lucey MR, Osman F, Rice JP. Musto JA, et al. Among authors: schell t. Clin Gastroenterol Hepatol. 2024 May 8:S1542-3565(24)00432-4. doi: 10.1016/j.cgh.2024.04.025. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 38729395

4

Relationships of State Alcohol Policy Environments with Homicides and Suicides.

Murphy JP, Smart R, Schell TL, Nicosia N, Naimi TS. Murphy JP, et al. Among authors: schell tl. Am J Prev Med. 2024 Apr 9:S0749-3797(24)00114-4. doi: 10.1016/j.amepre.2024.04.002. Online ahead of print. Am J Prev Med. 2024. PMID: 38604458 Free article.

5

Pharmacological agents targeting drug-tolerant persister cells in cancer.

Chen YC, Gowda K, Amin S, Schell TD, Sharma AK, Robertson GP. Chen YC, et al. Among authors: schell td. Pharmacol Res. 2024 May;203:107163. doi: 10.1016/j.phrs.2024.107163. Epub 2024 Apr 1. Pharmacol Res. 2024. PMID: 38569982 Free article. Review.

6

Geographic and Demographic Differences in the Proportion of Individuals Living in Households With a Firearm, 1990-2018.

Morral AR, Smart R, Schell TL, Vegetabile B, Thomas E. Morral AR, et al. Among authors: schell tl. JAMA Netw Open. 2024 Feb 5;7(2):e240562. doi: 10.1001/jamanetworkopen.2024.0562. JAMA Netw Open. 2024. PMID: 38416496 Free PMC article.

7

A Practical Update on COVID-19 and Inflammatory Bowel Disease: COVID-19 Disease Risk and Vaccine Safety and Efficacy.

Schell TL, Caldera F. Schell TL, et al. Gastroenterol Hepatol (N Y). 2024 Feb;20(2):88-97. Gastroenterol Hepatol (N Y). 2024. PMID: 38414911 Free PMC article.

8

Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy.

Caldera F, Rolak S, Farraye FA, Necela BM, Cogen D, Zona EE, Schell TL, Ramirez OR, Almasry M, Chun K, Hayney MS, Knutson KL. Caldera F, et al. Among authors: schell tl. Clin Transl Gastroenterol. 2024 Apr 1;15(4):e00688. doi: 10.14309/ctg.0000000000000688. Clin Transl Gastroenterol. 2024. PMID: 38349178 Free PMC article.

9

Uptake Rates of Three COVID-19 Vaccine Doses and Risk Factors for Incomplete Vaccination Among Patients With Inflammatory Bowel Disease Residing in Wisconsin: A Single-Center Cohort.

Schell TL, Mailig MA, Almasry M, Lazarus S, Richard LJ, Tippins K, Weiss J, Hayney MS, Caldera F. Schell TL, et al. WMJ. 2023 Dec;122(5):450-455. WMJ. 2023. PMID: 38180944 Free article.

10

Immune Responses in Oral Papillomavirus Clearance in the MmuPV1 Mouse Model.

Brendle SA, Li JJ, Walter V, Schell TD, Kozak M, Balogh KK, Lu S, Christensen ND, Zhu Y, El-Bayoumy K, Hu J. Brendle SA, et al. Among authors: schell td. Pathogens. 2023 Dec 14;12(12):1452. doi: 10.3390/pathogens12121452. Pathogens. 2023. PMID: 38133335 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

219 results

Search Page